Infection Surveillance Solutions Market Size, Share & Trends Analysis Report By Product & Services (Software (On-premise Software, Web-based Software), Up to 50 hp (Product Support & Maintenance Services, Implementation Services, Training & Consulting services), By End User, By Region, And By Segment Forecasts, 2023-2031

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Infection Surveillance Solutions Market Snapshot Chapter 4. Global Infection Surveillance Solutions Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. COVID-19 Impact Analysis Chapter 5. Market Segmentation 1: By Product & Services Estimates & Trend Analysis 5.1. By Product & Services & Market Share, 2019-2031 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Product & Services: 5.2.1. Software 5.2.1.1. On-premise Software 5.2.1.2. Web-based Software 5.2.2. Services 5.2.2.1. Product Support & Maintenance Services 5.2.2.2. Implementation Services 5.2.2.3. Training & Consulting services Chapter 6. Market Segmentation 2: By End User Estimates & Trend Analysis 6.1. By Product & Services & Market Share, 2019-2031 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By End User: 6.2.1. Hospitals 6.2.1.1. Large Hospitals 6.2.1.2. Medium Sized Hospitals 6.2.1.3. Small Hospitals 6.2.2. Long-term Care Facilities 6.2.2.1. Nursing Homes 6.2.2.2. Skilled Nursing Facilities 6.2.2.3. Assisted- Living Facilities 6.2.3. Other End Users Chapter 7. Infection Surveillance Solutions Market Segmentation 3: Regional Estimates & Trend Analysis 7.1. North America 7.1.1. North America Infection Surveillance Solutions Market revenue (US$ Million) estimates and forecasts By Product & Services, 2023-2031 7.1.2. North America Infection Surveillance Solutions Market revenue (US$ Million) estimates and forecasts By End User, 2023-2031 7.1.3. North America Infection Surveillance Solutions Market revenue (US$ Million) estimates and forecasts by country, 2023-2031 7.1.3.1. U.S. 7.1.4. Canada 7.2. Europe 7.2.1. Europe Infection Surveillance Solutions Market revenue (US$ Million) By Product & Services, 2023-2031 7.2.2. Europe Infection Surveillance Solutions Market revenue (US$ Million) estimates and forecasts By End User, 2023-2031 7.2.3. Europe Infection Surveillance Solutions Market revenue (US$ Million) by country, 2023-2031 7.2.3.1. Germany 7.2.3.2. Poland 7.2.3.3. France 7.2.3.4. Italy 7.2.3.5. Spain 7.2.3.6. UK 7.2.3.7. Rest of Europe 7.3. Asia Pacific 7.3.1. Asia Pacific Infection Surveillance Solutions Market revenue (US$ Million) By Product & Services, 2023-2031 7.3.2. Asia Pacific Infection Surveillance Solutions Market revenue (US$ Million) estimates and forecasts By End User, 2023-2031 7.3.3. Asia Pacific Infection Surveillance Solutions Market revenue (US$ Million) by country, 2023-2031 7.3.3.1. China 7.3.3.2. India 7.3.3.3. Japan 7.3.3.4. Australia 7.3.3.5. Rest of Asia Pacific 7.4. Latin America 7.4.1. Latin America Infection Surveillance Solutions Market revenue (US$ Million) By Product & Services, 2023-2031 7.4.2. Latin America Infection Surveillance Solutions Market revenue (US$ Million) estimates and forecasts By End User, 2023-2031 7.4.3. Latin America Infection Surveillance Solutions Market revenue (US$ Million) By country, (US$ Million) 2023-2031 7.4.3.1. Brazil 7.4.3.2. Rest of Latin America 7.5. Middle East & Africa 7.5.1. Middle East & Africa Infection Surveillance Solutions Market revenue (US$ Million) By Product & Services, (US$ Million) 7.5.2. Middle East & Africa Infection Surveillance Solutions Market revenue (US$ Million) estimates and forecasts By End User, 2023-2031 7.5.3. Middle East & Africa Infection Surveillance Solutions Market revenue (US$ Million) by country, (US$ Million) 2023-2031 7.5.3.1. South Africa 7.5.3.2. GCC Countries 7.5.3.3. Rest of MEA Chapter 8. Competitive Landscape 8.1. Major Mergers and Acquisitions/Strategic Alliances 8.2. Company Profiles 8.2.1. Becton, Dickinson and Company (US) 8.2.2. Premier, Inc. (US) 8.2.3. Wolters Kluwer N.V. (Netherlands) 8.2.4. Cerner Corporation (US) 8.2.5. Baxter International Inc. (US) 8.2.6. GOJO Industries, Inc. (US) 8.2.7. Clinisys (US) 8.2.8. Deb Group Ltd. (UK) 8.2.9. BioVigil Healthcare Systems (US) 8.2.10. RLDatix (UK) 8.2.11. Merative (US) 8.2.12. Vecna Technologies, Inc. (US) 8.2.13. VigiLanz Corporation (US) 8.2.14. Ecolab (US) 8.2.15. Harris Healthcare (US) 8.2.16. PeraHealth (US) 8.2.17. Medexter Healthcare (Austria) 8.2.18. CenTrak, Inc. (US) 8.2.19. BioMerieux SA (France) 8.2.20. CKM Healthcare (Canada) 8.2.21. Asolva Inc. (US) 8.2.22. PointClickCare (Canada) 8.2.23. STANLEY Healthcare (US) 8.2.24. Vitalacy Inc. (US)